TB-PACTS data platform Mission:
The TB-PACTS data platform is designed to catalyze and accelerate TB research by curating and standardizing tuberculosis (TB) clinical trial data and making this data publicly available to qualified researchers. These researchers can access and analyze data in aggregate, or filter and view individual patient-level data from at least 26 clinical trials, including REMoxTB, RIFAQUIN and OFLUTUB. Additional trial data may become available in the future.
TB-PACTS data platform Partnership:
This initiative represents a collaborative partnership between the Special Programme for Research and Training in Tropical Diseases (TDR), the TB Alliance,St. George’s University of London, the U.S. CDC, Case Western University, the British Medical Research Council, Vital Strategies, Inc. and Critical Path Institute (C-Path).
This partnership continues to expand the scale of the TB-PACTS platform by engaging with other TB clinical data contributors and initiatives to secure additional datasets.
TB-PACTS data platform Content and Access:
The TB–PACTS data platform will catalog contemporary (TB) clinical trial data sets and make these data sets available to qualified researchers. Approved researchers can access patient-level data from at least 26 clinical trials, including REMoxTB, RIFAQUIN and OFLOTUB, eight additional TB Alliance trials, six CDC trials, and six Medical Research Council trials. Additional trial data is expected to be made available in the future.
For more information on TB-PACTS or how your organization can contribute data, please contact:
Director, Data Collaboration Center